SRL Diagnostics, a leading diagnostic chain in India, has released a 3-year long 2013-2015 data mining survey on celiac disease at a pan India level. The data reveals that there has been an increment in the number of samples received for testing at SRL by 26 per cent in the last 3 years. Of the total number of samples received for testing, 18 per cent were found to be abnormal. Celiac disease is slightly more common in Indian males (20 per cent) than females (17 per cent).
Celiac disease (CD) is a chronic immune-mediated inflammation of our gut triggered by exposure to gluten (found in wheat, barley, rye, oat, spelt and malt) in food items. It is a condition in which gluten damages the intestines and reduces its ability to absorb food. It affects 1 per cent of the population in many regions of the world.
The prevalence of this disease is found in patients with family history of CD or a personal history of autoimmune disease, including that of thyroid, liver, or type 1 diabetes mellitus.
However a pre-requisite for celiac disease is gluten sensitivity. At an early stage the disease remains as non-celiac gluten sensitivity, but if not taken care of, slowly progresses to overt celiac disease.
Northern zone had highest percentage of abnormality with 20 percent followed by western zone with 17 per cent. Among the zones, southern and eastern India showed the lowest percentage of abnormality with 8 per cent and 15 per cent respectively.
Dr. Deepa Dave, director, lab operations “There is a significant need for reaching out and making people aware of the causes, symptoms, treatment and importance of testing for celiac disease. SRL Diagnostics’ in-house data analysis on celiac tests assesses the nationwide abnormalities in test results in both the genders residing in various cities representing diverse geographic origin, occupation, and socio-economic status and food habits. ”
She further added “The population in North India showed a higher frequency (20 per cent) of positive test reports for celiac disease than in any other zones. This can be due to high consumption of gluten-rich food by the people residing in this zone. South Indian population seems to be the least affected by gluten sensitivity (8 per cent) and this observation correlates well with their diet, which is rice based. “
As per SRL’s analysis of the positive samples, children in the 0 to 10 years age group were seen to be the most affected in all four zones of India. Although celiac disease can be confirmed through an endoscopic biopsy taken from the gut, serologic tests in CD should be done as a first step in individuals with symptoms suggestive of CD.
SRL Diagnostics has 322 networking laboratories, including 10 Reference Labs, 4 Centers of Excellence, 26 radiology/imaging centers, 39 NBL accredited labs, 4 CAP accredited labs and a footprint spanning over 7272 collection points. The company has large labs in Dubai, Sri Lanka and Nepal, and also about 58 collection points in various countries outside India.
SRL Diagnostics is the veritable pioneer of medical diagnostics in India. Established in 1995, the diagnostic center has been imbued with a mission to deliver gold standard diagnostic services, both in the field of laboratory medicine and radiology including high-end Imaging services.
SRL carries out 125,000 tests per day. It is often stated that on the human body about 4000 different types of diagnostics tests could be performed. SRL has over 3800 tests in its repertoire which is the largest menu of tests in India.
SRL has the most Accredited Lab Network in India comprising of 39 NABL accredited labs and 4 CAP accredited labs. SRL continues to revolutionize diagnostic services in India by ushering in the most specialized technologies and innovative services.
Its Research &Innovation division is ISO certified and was the first lab in the private sector was recognized by the government of India's department of scientific and industrial research. SRL’s wide range of tests provides quality diagnostic, prognostic and monitoring services to other path labs, hospitals and patients. It also provides services of testing samples for the multinational and Indian pharmaceutical companies/ CROs undertaking phase III/ IV clinical trial work, thereby supporting their international regulatory submissions.